PDB4 MODELING HEALTH AND ECONOMIC OUTCOMES ASSOCIATED WITH EXENATIDE ONCE-WEEKLY VERSUS INSULIN AND PIOGLITAZONE TREATMENT FOR TYPE-2 DIABETES
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.512
https://www.valueinhealthjournal.com/article/S1098-3015(11)00651-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1076
First Page :
A91
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00651-6&doi=10.1016/j.jval.2011.02.512